Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
C Xue, Q Chu, Q Zheng, S Jiang, Z Bao, Y Su… - Signal transduction and …, 2022 - nature.com
Cancer is one of the major diseases threatening human life and health worldwide.
Epigenetic modification refers to heritable changes in the genetic material without any …
Epigenetic modification refers to heritable changes in the genetic material without any …
Non-coding RNA m6A modification in cancer: mechanisms and therapeutic targets
DH Chen, JG Zhang, CX Wu, Q Li - Frontiers in cell and …, 2021 - frontiersin.org
Recently, N6-methyl-adenosine (m6A) ribonucleic acid (RNA) modification, a critical and
common internal RNA modification in higher eukaryotes, has generated considerable …
common internal RNA modification in higher eukaryotes, has generated considerable …
[HTML][HTML] N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction
J Li, F Wang, Y Liu, H Wang, B Ni - International Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract N 6-methyladenosine (m 6 A), the most abundant RNA modification in eukaryotes,
plays a pivotal role in regulating many cellular and biological processes. Aberrant m 6 A …
plays a pivotal role in regulating many cellular and biological processes. Aberrant m 6 A …
A genetic variant in gene NDUFAF4 confers the risk of non‐small cell lung cancer by perturbing hsa‐miR‐215 binding
T Long, J Li, T Yin, K Liu, Y Wang, J Long… - Molecular …, 2024 - Wiley Online Library
Abstract Hsa‐microRNA‐215 (hsa‐miR‐215) plays multiple roles in carcinogenesis through
regulating its target genes. Genetic variants in hsa‐miR‐215 target sites thus may affect hsa …
regulating its target genes. Genetic variants in hsa‐miR‐215 target sites thus may affect hsa …
The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
L Yao, CF Man, R He, L He, JB Huang, SY Xiang… - Frontiers in …, 2022 - frontiersin.org
N6-methyladenosine (m6A) is the most common epigenetic modification of eukaryotic RNA,
which can participate in the growth and development of the body and a variety of …
which can participate in the growth and development of the body and a variety of …
Role of N6-methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer
T Ye, J Wang, H Zhao, G Zhao… - … Journal of Oncology, 2022 - spandidos-publications.com
Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-associated mortality,
and is predicted to become the third leading cause of cancer-associated mortality by the …
and is predicted to become the third leading cause of cancer-associated mortality by the …
Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes
E Jia, N Ren, B Guo, Z Cui, B Zhang, J Xue - World Journal of Surgical …, 2022 - Springer
Abstract Background N6-methyladenosine (m6A) is the most prevalent modification in
mRNA in biological processes and associated with various malignant tumor initiation and …
mRNA in biological processes and associated with various malignant tumor initiation and …
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
Y Zhang, W Gu, Y Shao - Discover Oncology, 2023 - Springer
Radiation therapy is an important tool for malignant tumors, and its tolerance needs to be
addressed. In recent years, several studies have shown that regulators of aberrant m6A …
addressed. In recent years, several studies have shown that regulators of aberrant m6A …
Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis
HM Li, F Tang, LJ Wang, Q Huang, HF Pan… - Frontiers in Public …, 2022 - frontiersin.org
N6-Methyladenosine (m6A) is associated with many biological processes and the
development of multiple diseases. The aim of this study was to analyze the association of …
development of multiple diseases. The aim of this study was to analyze the association of …
Genome-wide identification of m6A-associated single-nucleotide polymorphisms in colorectal cancer
H Zhao, J Jiang, M Wang, Z Xuan - … and Personalized Medicine, 2021 - Taylor & Francis
Background N6-methyladenosine (m6A)-associated single-nucleotide polymorphisms
(SNPs) play important roles in cancers, with previous research suggesting potential …
(SNPs) play important roles in cancers, with previous research suggesting potential …